GGrantIndex
← Leaderboards

David M Gamm

University Of Wisconsin-Madison

$16,807,477
Attributed
$32,319,807
Total exposure
11
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.7M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$32,319,807 · 11

By mechanism

R24$7,812,597 · 1
U24$7,111,894 · 1
U19$7,069,757 · 2
U01$5,331,324 · 4
R01$4,130,600 · 2
K08$863,635 · 1

Most similar at University Of Wisconsin-Madison

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsRetinaGenesPhotoreceptorsStructureStructure Of Retinal Pigment EpitheliumVisionInduced Pluripotent Stem CellHuman Pluripotent Stem CellTissuesMutationResponseInheritedLeadMolecularBaseRetinal Progenitor CellGenome EditingGene TherapyBiological ModelsStem Cell BiologyCell Differentiation ProcessElectrophysiology (Science)Proteins

Grant awards (43)

Restoring Vision with High-Fidelity Nonsense Codon Correction$1,684,745
R24 · FY2025 · EY
Human Cell Assay Core$1,010,521
U19 · FY2025 · NS · contact PI
Develop an engineered Cas effector for in vivo cell-targeted delivery in the eye to treat autosomal dominant BEST disease$2,008,538
U19 · FY2024 · NS · contact PI
Restoring Vision with High-Fidelity Nonsense Codon Correction$1,684,745
R24 · FY2024 · EY
Human Cell Assay Core$1,010,521
U19 · FY2024 · NS · contact PI
Human Cell Assay Core$1,679,849
U19 · FY2023 · NS · contact PI
Restoring Vision with High-Fidelity Nonsense Codon Correction$1,460,184
R24 · FY2023 · EY
Develop an engineered Cas effector for in vivo cell-targeted delivery in the eye to treat autosomal dominant BEST disease$1,360,328
U19 · FY2023 · NS · contact PI
Restoring Vision with High-Fidelity Nonsense Codon Correction$1,443,079
R24 · FY2022 · EY
Retinal disease models for translational photoreceptor replacement$1,374,254
U24 · FY2022 · EY
Single Cell Profiling To Define Biomarkers Of Photoreceptor Dysfunction After Gene Editing Within PSC-Derived Organoids$611,987
U01 · FY2022 · EY
Restoring Vision with High-Fidelity Nonsense Codon Correction$42,500
R24 · FY2022 · EY
Restoring Vision with High-Fidelity Nonsense Codon Correction$1,454,844
R24 · FY2021 · EY
Retinal disease models for translational photoreceptor replacement$1,373,869
U24 · FY2021 · EY
Single Cell Profiling To Define Biomarkers Of Photoreceptor Dysfunction After Gene Editing Within PSC-Derived Organoids$611,987
U01 · FY2021 · EY
Restoring Vision with High-Fidelity Nonsense Codon Correction$42,500
R24 · FY2021 · EY
Retinal disease models for translational photoreceptor replacement$1,373,524
U24 · FY2020 · EY
Single Cell Profiling To Define Biomarkers Of Photoreceptor Dysfunction After Gene Editing Within PSC-Derived Organoids$611,987
U01 · FY2020 · EY
Retinal disease models for translational photoreceptor replacement$213,628
U24 · FY2020 · EY
Retinal disease models for translational photoreceptor replacement$1,374,792
U24 · FY2019 · EY
Single Cell Profiling To Define Biomarkers Of Photoreceptor Dysfunction After Gene Editing Within PSC-Derived Organoids$602,712
U01 · FY2019 · EB
Retinal disease models for translational photoreceptor replacement$1,401,827
U24 · FY2018 · EY
Screening for Molecules that Promote Photoreceptor Synaptogenesis$671,689
U01 · FY2018 · EY
Single Cell Profiling To Define Biomarkers Of Photoreceptor Dysfunction After Gene Editing Within PSC-Derived Organoids$616,444
U01 · FY2018 · HL
Disease Mechanisms in Best Disease$491,519
R01 · FY2018 · EY
Screening for Molecules that Promote Photoreceptor Synaptogenesis$150,000
U01 · FY2018 · EY
Screening for Molecules that Promote Photoreceptor Synaptogenesis$671,182
U01 · FY2017 · EY
Disease Mechanisms in Best Disease$491,519
R01 · FY2017 · EY
Mechanisms of Retinogenesis in Human Stem Cells$382,460
R01 · FY2017 · EY · contact PI
Screening for Molecules that Promote Photoreceptor Synaptogenesis$97,500
U01 · FY2017 · EY
Screening for Molecules that Promote Photoreceptor Synaptogenesis$685,836
U01 · FY2016 · EY
Disease Mechanisms in Best Disease$491,519
R01 · FY2016 · EY
Disease Mechanisms in Best Disease$501,681
R01 · FY2015 · EY
Mechanisms of Retinogenesis in Human Stem Cells$349,272
R01 · FY2014 · EY · contact PI
Mechanisms of Retinogenesis in Human Stem Cells$338,580
R01 · FY2013 · EY · contact PI
Mechanisms of Retinogenesis in Human Stem Cells$356,400
R01 · FY2012 · EY · contact PI
Mechanisms of Retinogenesis in Human Stem Cells$356,400
R01 · FY2011 · EY · contact PI
Mechanisms of Retinogenesis in Human Stem Cells$371,250
R01 · FY2010 · EY · contact PI
Culture and Transplantation of Human Retinal Spheres$182,246
K08 · FY2008 · EY · contact PI
Culture and Transplantation of Human Retinal Spheres$177,122
K08 · FY2007 · EY · contact PI
Culture and Transplantation of Human Retinal Spheres$172,166
K08 · FY2006 · EY · contact PI
Culture and Transplantation of Human Retinal Spheres$167,370
K08 · FY2005 · EY
Culture and Transplantation of Human Retinal Spheres$164,731
K08 · FY2004 · EY